Asia · Regional markets · Pulse (Maeil Business)
Hugel’s nine-month sales rise 15% on strong Korea, Europe demand
South Korean biopharmaceutical company Hugel reported a 15 percent increase in revenue for the first nine months of 2026, driven by stronger sales of botulinum toxin products,…
Read the full article on Pulse (Maeil Business) Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (pulse.mk.co.kr)

